EFFECTS OF TESTOSTERONE SUPPLEMENTATION ON MARKERS OF THE METABOLIC SYNDROME AND INFLAMMATION IN HYPOGONADAL MEN WITH THE METABOLIC SYNDROME: THE DOUBLE-BLINDED PLACEBO-CONTROLLED MOSCOW STUDY ArticleKalinchenko S.Y., Tishova Y.A., Mskhalaya G.J., Gooren L.J.G., Giltay E.J., Saad F.Clinical Endocrinology. Том 73. 2010. С. 602-612
SOMATOSTATIN RECEPTOR 2 EXPRESSION IN THE HUMAN ENDOMETRIUM THROUGH THE MENSTRUAL CYCLE ArticleRichmond I., Maguiness S., Robinson J., Helboe L., Adams I.P., Drummond N.S., Atkin S.L., Green V.L.Clinical Endocrinology. Том 56. 2002. С. 609-614
LIPIDS AND LIPOPROTEIN SUBFRACTIONS IN WOMEN WITH PCOS: RELATIONSHIP TO METABOLIC AND ENDOCRINE PARAMETERS ArticlePirwany I.R., Fleming R., Greer I.A., Packard C.J., Sattar N.Clinical Endocrinology. Том 54. 2001. С. 447-453
THE EFFECTS OF SIX MONTHS OF TREATMENT WITH A LOW-DOSE OF CONJUGATED OESTROGENS IN MENOPAUSAL WOMEN ArticleSchlegel W., Petersdorf L.I., Junker R., Schulte H., Ebert C., Von Eckardstein A.Clinical Endocrinology. Том 51. 1999. С. 643-651
VARIATIONS IN ERYTHROCYTE ANTIOXIDANT GLUTATHIONE PEROXIDASE ACTIVITY DURING THE MENSTRUAL CYCLE ArticleMassafra Cosimo, De Felice Claudio, Gioia Dino, Buonocore GiuseppeClinical Endocrinology. Том 49. 1998. С. 63-67